These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30596685)

  • 1. Differences in the determinants of right ventricular and regional left ventricular long-axis dysfunction in Friedreich ataxia.
    Peverill RE; Donelan L; Corben LA; Delatycki MB
    PLoS One; 2018; 13(12):e0209410. PubMed ID: 30596685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change.
    Mottram PM; Delatycki MB; Donelan L; Gelman JS; Corben L; Peverill RE
    J Am Soc Echocardiogr; 2011 Jul; 24(7):782-9. PubMed ID: 21570254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.
    Kelly M; Bagnall RD; Peverill RE; Donelan L; Corben L; Delatycki MB; Semsarian C
    J Mol Cell Cardiol; 2011 Nov; 51(5):848-54. PubMed ID: 21771600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular structural and functional changes in Friedreich ataxia - Relationship with body size, sex, age and genetic severity.
    Peverill RE; Romanelli G; Donelan L; Hassam R; Corben LA; Delatycki MB
    PLoS One; 2019; 14(11):e0225147. PubMed ID: 31721791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of Left Ventricular Dysfunction in Friedreich's Ataxia in a 16-Year Observational Study.
    Legrand L; Diallo A; Monin ML; Ewenczyk C; Charles P; Isnard R; Vicaut E; Montalescot G; Durr A; Pousset F
    Am J Cardiovasc Drugs; 2020 Apr; 20(2):209-216. PubMed ID: 31650522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the effects of Friedreich ataxia on the left ventricle using T1 mapping and late gadolinium enhancement.
    Peverill RE; Lin KY; Fogel MA; Cheung MMH; Moir WS; Corben LA; Cahoon G; Delatycki MB
    PLoS One; 2024; 19(5):e0303969. PubMed ID: 38814901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design.
    Saccà F; Puorro G; Antenora A; Marsili A; Denaro A; Piro R; Sorrentino P; Pane C; Tessa A; Brescia Morra V; Cocozza S; De Michele G; Santorelli FM; Filla A
    PLoS One; 2011 Mar; 6(3):e17627. PubMed ID: 21412413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia.
    Bit-Avragim N; Perrot A; Schöls L; Hardt C; Kreuz FR; Zühlke C; Bubel S; Laccone F; Vogel HP; Dietz R; Osterziel KJ
    J Mol Med (Berl); 2001; 78(11):626-32. PubMed ID: 11269509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond loss of frataxin: the complex molecular pathology of Friedreich ataxia.
    Evans-Galea MV; Lockhart PJ; Galea CA; Hannan AJ; Delatycki MB
    Discov Med; 2014 Jan; 17(91):25-35. PubMed ID: 24411698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel GAA-repeat-expansion-based mouse model of Friedreich's ataxia.
    Anjomani Virmouni S; Ezzatizadeh V; Sandi C; Sandi M; Al-Mahdawi S; Chutake Y; Pook MA
    Dis Model Mech; 2015 Mar; 8(3):225-35. PubMed ID: 25681319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A GAA repeat expansion reporter model of Friedreich's ataxia recapitulates the genomic context and allows rapid screening of therapeutic compounds.
    Lufino MM; Silva AM; Németh AH; Alegre-Abarrategui J; Russell AJ; Wade-Martins R
    Hum Mol Genet; 2013 Dec; 22(25):5173-87. PubMed ID: 23943791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal strain in Friedreich Ataxia: a potential marker for early left ventricular dysfunction.
    St John Sutton M; Ky B; Regner SR; Schadt K; Plappert T; He J; D'Souza B; Lynch DR
    Echocardiography; 2014; 31(1):50-7. PubMed ID: 23834395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.
    Pousset F; Legrand L; Monin ML; Ewenczyk C; Charles P; Komajda M; Brice A; Pandolfo M; Isnard R; Tezenas du Montcel S; Durr A
    JAMA Neurol; 2015 Nov; 72(11):1334-41. PubMed ID: 26414159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAA repeat expansion mutation mouse models of Friedreich ataxia exhibit oxidative stress leading to progressive neuronal and cardiac pathology.
    Al-Mahdawi S; Pinto RM; Varshney D; Lawrence L; Lowrie MB; Hughes S; Webster Z; Blake J; Cooper JM; King R; Pook MA
    Genomics; 2006 Nov; 88(5):580-90. PubMed ID: 16919418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic promoter silencing in Friedreich ataxia is dependent on repeat length.
    Chutake YK; Lam C; Costello WN; Anderson M; Bidichandani SI
    Ann Neurol; 2014 Oct; 76(4):522-8. PubMed ID: 25112975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic instability of the expanded GAA repeats in Friedreich's ataxia.
    Long A; Napierala JS; Polak U; Hauser L; Koeppen AH; Lynch DR; Napierala M
    PLoS One; 2017; 12(12):e0189990. PubMed ID: 29261783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Doppler imaging is a sensitive echocardiographic technique to detect subclinical systolic and diastolic dysfunction of both ventricles in type 1 diabetes mellitus.
    Suran D; Sinkovic A; Naji F
    BMC Cardiovasc Disord; 2016 Apr; 16():72. PubMed ID: 27102111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleviating GAA Repeat Induced Transcriptional Silencing of the Friedreich's Ataxia Gene During Somatic Cell Reprogramming.
    Polak U; Li Y; Butler JS; Napierala M
    Stem Cells Dev; 2016 Dec; 25(23):1788-1800. PubMed ID: 27615158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich ataxia patients.
    Castaldo I; Pinelli M; Monticelli A; Acquaviva F; Giacchetti M; Filla A; Sacchetti S; Keller S; Avvedimento VE; Chiariotti L; Cocozza S
    J Med Genet; 2008 Dec; 45(12):808-12. PubMed ID: 18697824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central role and mechanisms of β-cell dysfunction and death in friedreich ataxia-associated diabetes.
    Cnop M; Igoillo-Esteve M; Rai M; Begu A; Serroukh Y; Depondt C; Musuaya AE; Marhfour I; Ladrière L; Moles Lopez X; Lefkaditis D; Moore F; Brion JP; Cooper JM; Schapira AH; Clark A; Koeppen AH; Marchetti P; Pandolfo M; Eizirik DL; Féry F
    Ann Neurol; 2012 Dec; 72(6):971-82. PubMed ID: 23280845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.